Human Sperm Markers of Cryodamage Resistance

NCT ID: NCT02535377

Last Updated: 2021-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-02-12

Study Completion Date

2019-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sperm freezing has been employed for decades for male fertility preservation in cases of foreseeable or unexpected loss of fertility to guarantee future paternity, and also as a complement of assisted reproduction techniques.

Sperm quality after thawing is highly variable, even among consecutive samples from the same individual, with mean survival rates around 40%. To date, the molecular basis of the adequate resistance or intolerance to freezing/thawing protocols is unknown, and its knowledge can lead to improvement in the selection of the samples to be frozen and also in the adequate supplement of cryopreservation media. Microarray analysis provides a powerful tool to address the molecular explanation beyond this behaviour, yielding results about comparative messenger ribonucleic acid (mRNA)expression under the two different biological conditions: optimal and suboptimal survival.

Then, the aim of the investigators' study is to determine the genomic profile of sperm samples depending on their survival resistance to cryopreservation, to determine genes involved in cryodamage sensitivity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nested cases and controls design, with donor sperm samples frozen under conventional protocols, categorized depending on their good (GSR, n=20) (less than 20% motility decrease) or bad (BSR, n=20) (more than 20% motility decrease) survival rates. Sperm mRNA was extracted using Trizol protocol, suspended in diethylpyrocarbonate (DEPC)-treated water and frozen at -80 degrees until the microarray experiments were performed. RNAs were analyzed on Agilent Bioanalyzer 2100. Samples were pooled in 4 (5 samples/pool and 4 pools/group). Finally, 8 Agilent One colour Whole genome microarray (44K) were performed with pooled samples, 4 microarrays per group.

The results will be evaluate to detect those genes differentially expressed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High cryoresistance

High resistance to sperm cryopreservation (decreased sperm motility \<20%)

Sperm cryopreservation

Intervention Type OTHER

Sperm from the different groups are cryopreserved to evaluate their resistance to preservation.

Low cryoresistance

Low resistance to sperm cryopreservation (decreased sperm motility \>20%)

Sperm cryopreservation

Intervention Type OTHER

Sperm from the different groups are cryopreserved to evaluate their resistance to preservation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sperm cryopreservation

Sperm from the different groups are cryopreserved to evaluate their resistance to preservation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The criteria used for the inclusion of donors in the sperm bank will be considered:

* males from 18 to 35 years.
* good physical and psychological conditions and no hereditary diseases
* seminal parameters: concentration \> 40 million sperm / ml; percentage of progressive motility\> 50% percentage of normal forms\> 4%.
* For pregnancy rates after artificial insemination, only women\< 40 years without tubal pathologies and artificial insemination indications will be included.

Exclusion Criteria

All the population not included in the list of inclusion will be excluded.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Igenomix

INDUSTRY

Sponsor Role collaborator

Instituto Valenciano de Infertilidad, IVI Alicante

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elena Sellés Soriano

Molecular diagnostic of sperm cryoresistance of semen donors and clinical outcomes after artificial insemination. Optimization of sperm bank

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elena Sellés, PhD

Role: PRINCIPAL_INVESTIGATOR

Instituto Valenciano de Infertilidad, IVI Alicante

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IVI Alicante

Alicante, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Thurston LM, Siggins K, Mileham AJ, Watson PF, Holt WV. Identification of amplified restriction fragment length polymorphism markers linked to genes controlling boar sperm viability following cryopreservation. Biol Reprod. 2002 Mar;66(3):545-54. doi: 10.1095/biolreprod66.3.545.

Reference Type BACKGROUND
PMID: 11870056 (View on PubMed)

Thurston LM, Watson PF, Holt WV. Semen cryopreservation: a genetic explanation for species and individual variation? Cryo Letters. 2002 Jul-Aug;23(4):255-62.

Reference Type BACKGROUND
PMID: 12391486 (View on PubMed)

Holt WV, Medrano A, Thurston LM, Watson PF. The significance of cooling rates and animal variability for boar sperm cryopreservation: insights from the cryomicroscope. Theriogenology. 2005 Jan 15;63(2):370-82. doi: 10.1016/j.theriogenology.2004.09.018.

Reference Type BACKGROUND
PMID: 15626405 (View on PubMed)

Casas I, Sancho S, Briz M, Pinart E, Bussalleu E, Yeste M, Bonet S. Freezability prediction of boar ejaculates assessed by functional sperm parameters and sperm proteins. Theriogenology. 2009 Oct 15;72(7):930-48. doi: 10.1016/j.theriogenology.2009.07.001. Epub 2009 Aug 3.

Reference Type BACKGROUND
PMID: 19651432 (View on PubMed)

Garrido N, Martinez-Conejero JA, Jauregui J, Horcajadas JA, Simon C, Remohi J, Meseguer M. Microarray analysis in sperm from fertile and infertile men without basic sperm analysis abnormalities reveals a significantly different transcriptome. Fertil Steril. 2009 Apr;91(4 Suppl):1307-10. doi: 10.1016/j.fertnstert.2008.01.078. Epub 2008 Mar 25.

Reference Type BACKGROUND
PMID: 18367176 (View on PubMed)

Garcia-Herrero S, Meseguer M, Martinez-Conejero JA, Remohi J, Pellicer A, Garrido N. The transcriptome of spermatozoa used in homologous intrauterine insemination varies considerably between samples that achieve pregnancy and those that do not. Fertil Steril. 2010 Sep;94(4):1360-1373. doi: 10.1016/j.fertnstert.2009.07.1671. Epub 2009 Sep 30.

Reference Type BACKGROUND
PMID: 19796764 (View on PubMed)

Garcia-Herrero S, Garrido N, Martinez-Conejero JA, Remohi J, Pellicer A, Meseguer M. Ontological evaluation of transcriptional differences between sperm of infertile males and fertile donors using microarray analysis. J Assist Reprod Genet. 2010 Feb;27(2-3):111-20. doi: 10.1007/s10815-010-9388-5. Epub 2010 Feb 2.

Reference Type BACKGROUND
PMID: 20127162 (View on PubMed)

Rahana AR, Ng SP, Leong CF, Rahimah MD. Comparison between mechanical freezer and conventional freezing using liquid nitrogen in normozoospermia. Singapore Med J. 2011 Oct;52(10):734-7.

Reference Type BACKGROUND
PMID: 22009393 (View on PubMed)

Gadea J, Molla M, Selles E, Marco MA, Garcia-Vazquez FA, Gardon JC. Reduced glutathione content in human sperm is decreased after cryopreservation: Effect of the addition of reduced glutathione to the freezing and thawing extenders. Cryobiology. 2011 Feb;62(1):40-6. doi: 10.1016/j.cryobiol.2010.12.001. Epub 2010 Dec 13.

Reference Type BACKGROUND
PMID: 21156167 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1406-ALC-048-ES

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.